Medical News

RSS

OSI Systems reports revenues of $204 million for third quarter fiscal 2014

OSI Systems, Inc. today announced financial results for the third fiscal quarter ended March 31, 2014, including, among other things, the introduction of reporting Adjusted EBITDA, a discussion of which can be found below, under the caption, "New Presentation of Non-GAAP Financial Measure."

30 Apr 2014

Purdue Pharma seeks FDA authorization to market once-daily hydrocodone bitartrate tablet

Purdue Pharma L.P. announced that it has filed a New Drug Application (NDA) with the U.S. Food & Drug Administration seeking authorization to market a once-daily, single-entity hydrocodone bitartrate tablet (HYD).

30 Apr 2014

Cutting-edge EmbryoScope technology now available to couples seeking fertility treatment in Florida

The latest in cutting-edge technology, The EmbryoScope, is now available to couples seeking fertility treatment in Florida at IVF FLORIDA Reproductive Associates.

30 Apr 2014

Boyd Coatings announces availability of six PTFE colors

Boyd Coatings Research Co., Inc. has announced the availability of six PTFE colors - all of which are created with the company's new, fully-validated and FDA-compliant, Zero PFOA PTFE formula.

30 Apr 2014

Sheffield professor awarded prestigious Camillo Golgi Prize for outstanding contribution to medicine

A CONSULTANT who first described how diabetic nerve damage is caused by impaired circulation of the nerves has been awarded one of the most coveted international prizes in medicine in recognition of his outstanding contribution to the field.

30 Apr 2014

Hospira’s net sales increase 6.3% to $1.1B in first quarter 2014

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today reported results for the first quarter ended March 31, 2014.

30 Apr 2014

InspireMD initiates Voluntary Field Action for MGuard Prime EPS stent dislodgements

InspireMD, Inc., a leader in embolic protection systems (EPS), today announced that it has initiated a Voluntary Field Action (VFA) following recent reports of MGuard Prime EPS stent dislodgements.

30 Apr 2014

Otonomy secures $49M in oversubscribed Series D round of financing

Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced it has secured $49 million in an oversubscribed Series D round of financing.

30 Apr 2014

FitLife Brands reports record revenue of $6.3M in first quarter 2014

FitLife Brands, Inc., an international provider of innovative and proprietary nutritional supplements for health conscious consumers marketed under the brand names NDS Nutrition Products™ (NDS), PMD®, SirenLabs® and CoreActive® today announced financial results for the first quarter ended March 31, 2014.

30 Apr 2014

FAM hosts 13th annual event at Webber Cancer Center to benefit patients with fibromyalgia

The Fibromyalgia Association of Michigan (FAM) will host its 13th annual event at the Webber Cancer Center at St. John Macomb-Oakland Hospital on 11800 12 Mile Road from 12:30 - 5:30 PM.

30 Apr 2014

Actavis’ net revenue increases 40% to $2.66B in Q1 2014

Actavis plc today reported net revenue increased 40 percent to $2.66 billion for the first quarter ended March 31, 2014, compared to $1.90 billion in the first quarter 2013.

30 Apr 2014

Boehringer announces first results of Phase III INPULSIS trials at 2014 ATS International Conference

Boehringer Ingelheim announced today that the first results of the two confirmatory Phase III INPULSISTM trials, investigating nintedanib* in the treatment of idiopathic pulmonary fibrosis (IPF), will be presented at the 2014 American Thoracic Society (ATS) International Conference taking place 16 - 21 May in San Diego

30 Apr 2014

LCA-Vision's revenues decrease $25.5M to 9.8% in first quarter 2014

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three months ended March 31, 2014.

30 Apr 2014

Alkermes reports financial results for first quarter of 2014

Alkermes plc today reported financial results for the first quarter of 2014. "During the quarter, we continued to generate positive cash flow, reflecting the strength of our commercial business and enabling us to invest in our advancing late-stage pipeline and prepare for the launch of aripiprazole lauroxil," commented James Frates, Chief Financial Officer of Alkermes.

30 Apr 2014

Research helps unpick long-standing mystery about how dietary fibre supresses appetite

New research has helped unpick a long-standing mystery about how dietary fibre supresses appetite. In a study led by Imperial College London and the Medical Research Council (MRC), an international team of researchers identified an anti-appetite molecule called acetate that is naturally released when we digest fibre in the gut.

30 Apr 2014

Denmark and China announce food safety partnership

On 25 April, a new memorandum of understanding between DTU and CFSA was signed by Martin Bends-e, DTU Senior Vice President and Dean, at a ceremony in Beijing witnessed by HRH Queen Margrethe II and Prince Henrik of Denmark.

30 Apr 2014

Braeburn announces new clinical trial for Probuphine based on clear guidance from FDA

Braeburn Pharmaceuticals announced today the initiation of a new clinical trial for Probuphine® based on clear guidance from the U.S. Food and Drug Administration (FDA). The study, which was submitted for FDA review in mid-March, is expected to begin enrollment by mid-year and to be completed by the middle of 2015.

30 Apr 2014

Medical News

OSI Systems reports revenues of $204 million for third quarter fiscal 2014

Purdue Pharma seeks FDA authorization to market once-daily hydrocodone bitartrate tablet

Cutting-edge EmbryoScope technology now available to couples seeking fertility treatment in Florida

Boyd Coatings announces availability of six PTFE colors

Sheffield professor awarded prestigious Camillo Golgi Prize for outstanding contribution to medicine

Hospira’s net sales increase 6.3% to $1.1B in first quarter 2014

InspireMD initiates Voluntary Field Action for MGuard Prime EPS stent dislodgements

Otonomy secures $49M in oversubscribed Series D round of financing

FitLife Brands reports record revenue of $6.3M in first quarter 2014

FAM hosts 13th annual event at Webber Cancer Center to benefit patients with fibromyalgia

Actavis’ net revenue increases 40% to $2.66B in Q1 2014

Boehringer announces first results of Phase III INPULSIS trials at 2014 ATS International Conference

LCA-Vision's revenues decrease $25.5M to 9.8% in first quarter 2014

Alkermes reports financial results for first quarter of 2014

Research helps unpick long-standing mystery about how dietary fibre supresses appetite

Denmark and China announce food safety partnership

Braeburn announces new clinical trial for Probuphine based on clear guidance from FDA

First Edition: April 30, 2014

Low baseline QOL scores does not predict worse survival in patients undergoing lung cancer surgery

Synergy reports positive top-line results from plecanatide phase 2b study in patients with IBS-C

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News